1. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2. |
Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? Cancer Commun (Lond), 2019, 39(1): 22.
|
3. |
Maule M, Merletti F. Cancer transition and priorities for cancer control. Lancet Oncol, 2012, 13(8): 745-746.
|
4. |
Cui M, You L, Ren X, et al. Long non-coding RNA PVT1 and cancer. Biochem Biophys Res Commun, 2016, 471(1): 10-14.
|
5. |
Guo K, Yao J, Yu Q, et al. The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression. Tumour Biol, 2017, 39(4): 1010428317699122.
|
6. |
Wu BQ, Jiang Y, Zhu F, et al. Long noncoding RNA PVT1 promotes EMT and cell proliferation and migration through downregulating p21 in pancreatic cancer cells. Technol Cancer Res Treat, 2017, 16(6): 819-827.
|
7. |
Guan Y, Kuo WL, Stilwell JL, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res, 2007, 13(19): 5745-5755.
|
8. |
Huang T, Liu HW, Chen JQ, et al. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer. Biomed Pharmacother, 2017, 88: 302-308.
|
9. |
Huang C, Liu S, Wang H, et al. LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer. Am J Transl Res, 2016, 8(11): 5025-5034.
|
10. |
Chen S, Zhou L, Wang Y. ALKBH5-mediated m6A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma. Cancer Cell Int, 2020, 20: 34.
|
11. |
Wang L, Xiao B, Yu T, et al. lncRNA PVT1 promotes the migration of gastric cancer by functioning as ceRNA of miR-30a and regulating Snail. J Cell Physiol, 2021, 236(1): 536-548.
|
12. |
Li B, Guo LH, Ban ZQ, et al. Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer. Medicine (Baltimore), 2020, 99(28): e21059.
|
13. |
Han Y, Li F, Xie J, et al. PVT1 Mediates cell proliferation, apoptosis and radioresistance in nasopharyngeal carcinoma through regulating miR-515-5p/PIK3CA axis. Cancer Manag Res, 2020, 12: 10077-10090.
|
14. |
Yu X, Zhao J, He Y. Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p/RUNX2 axis. J BUON, 2018, 23(1): 48-54.
|
15. |
Takahashi Y, Sawada G, Kurashige J, et al. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer, 2014, 110(1): 164-171.
|
16. |
Li Q, Dai Y, Wang F, et al. Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer. Neoplasma, 2016, 63(6): 977-983.
|
17. |
Tong D, Zou E, Bai L, et al. IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 inhibition. J BUON, 2020, 25(5): 2205-2214.
|
18. |
Liu F, Wu R, Guan L, et al. Knockdown of PVT1 suppresses colorectal cancer progression by regulating MiR-106b-5p/FJX1 axis. Cancer Manag Res, 2020, 12: 8773-8785.
|
19. |
Wu H, Wei M, Jiang X, et al. lncRNA PVT1 promotes tumorigenesis of colorectal cancer by stabilizing miR-16-5p and interacting with the VEGFA/VEGFR1/AKT axis. Mol Ther Nucleic Acids, 2020, 20: 438-450.
|
20. |
Fan H, Zhu JH, Yao XQ. Long non-coding RNA PVT1 as a novel potential biomarker for predicting the prognosis of colorectal cancer. Int J Biol Markers, 2018, 33(4): 415-422.
|
21. |
He F, Song Z, Chen H, et al. Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128. Oncogene, 2019, 38(2): 164-179.
|
22. |
Pan X, Cheng R, Zhu X, et al. Prognostic significance and diagnostic value of overexpressed lncRNA PVT1 in colorectal cancer. Clin Lab, 2019, 65(12).
|
23. |
Ping G, Xiong W, Zhang L, et al. Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer. Am J Transl Res, 2018, 10(1): 138-149.
|
24. |
Shigeyasu K, Toden S, Ozawa T, et al. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer. Mol Cancer, 2020, 19(1): 155.
|
25. |
任晓阳. 长链非编码 RNA PVT1 和 NEAT1 在食管鳞状细胞癌中的表达及意义. 青岛: 青岛大学, 2017.
|
26. |
Li PD, Hu JL, Ma C, et al. Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1. Oncotarget, 2017, 8(21): 34164-34176.
|
27. |
Zheng X, Hu H, Li S. High expression of lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal transition in esophageal cancer. Oncol Lett, 2016, 12(4): 2357-2362.
|
28. |
Xu Y, Li Y, Jin J, et al. LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma. Mol Cancer, 2019, 18(1): 141.
|
29. |
Huang C, Yu W, Wang Q, et al. Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients. Minerva Med, 2015, 106(3): 143-149.
|
30. |
Huang F, Chen W, Peng J, et al. LncRNA PVT1 triggers cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 axis. Mol Cancer, 2018, 17(1): 98.
|
31. |
Yuan CL, Li H, Zhu L, et al. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer. Neoplasma, 2016, 63(3): 442-449.
|
32. |
Ding J, Li D, Gong M, et al. Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer. Onco Targets Ther, 2014, 7: 1625-1630.
|
33. |
Li Y, Song S, Pizzi MP, et al. LncRNA PVT1 is a poor prognosticator and can be targeted by PVT1 antisense oligos in gastric adenocarcinoma. Cancers (Basel), 2020, 12(10): 2995.
|
34. |
Zhao J, Du P, Cui P, et al. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer. Oncogene, 2018, 37(30): 4094-4109.
|
35. |
Kong R, Zhang EB, Yin DD, et al. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer, 2015, 14: 82.
|
36. |
Niu J, Song X, Zhang X. Regulation of lncRNA PVT1 on miR-125 in metastasis of gastric cancer cells. Oncol Lett, 2020, 19(2): 1261-1266.
|
37. |
Luo Z, Cao P. Long noncoding RNA PVT1 promotes hepatoblastoma cell proliferation through activating STAT3. Cancer Manag Res, 2019, 11: 8517-8527.
|
38. |
Gou X, Zhao X, Wang Z. Long noncoding RNA PVT1 promotes hepatocellular carcinoma progression through regulating miR-214. Cancer Biomark, 2017, 20(4): 511-519.
|
39. |
Lan T, Yan X, Li Z, et al. Long non-coding RNA PVT1 serves as a competing endogenous RNA for miR-186-5p to promote the tumorigenesis and metastasis of hepatocellular carcinoma. Tumour Biol, 2017, 39(6): 1010428317705338.
|
40. |
Wang F, Yuan JH, Wang SB, et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology, 2014, 60(4): 1278-1290.
|
41. |
陈昌娜, 于红刚. 长链非编码RNA PVT1在肝癌组织中的表达与临床意义. 现代生物医学进展, 2019, 19(16): 3110-3114.
|
42. |
Ding C, Yang Z, Lv Z, et al. Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients. Oncol Lett, 2015, 9(2): 955-963.
|
43. |
Guo J, Hao C, Wang C, et al. Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2. Cancer Cell Int, 2018, 18: 98.
|
44. |
Yang L, Peng X, Jin H, et al. Long non-coding RNA PVT1 promotes autophagy as ceRNA to target ATG3 by sponging microRNA-365 in hepatocellular carcinoma. Gene, 2019, 697: 94-102.
|
45. |
吴大平, 吴焕良, 郑文宏, 等. 长链非编码 RNA PVT1 和 miR-30 d-5 p 在肝内胆管癌组织中的表达及其与预后相关性分析. 现代肿瘤医学, 2020, 28(16): 2833-2837.
|
46. |
Xu MD, Wang Y, Weng W, et al. A positive feedback loop of lncRNA- PVT1 and FOXM1 facilitates gastric cancer growth and invasion. Clin Cancer Res, 2017, 23(8): 2071-2080.
|
47. |
Guo K, Yao J, Yu Q, et al. The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression. Tumour Biol, 2017, 39(4): 1010428317699122.
|